A Safety Study of 3 Different Bowel Cleansing Preparations

ClinicalTrials.gov ID: NCT01501513

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01501513. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 4:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety, Tolerance and Efficacy Evaluation of 3 Different Bowel Cleansing Preparations in Adult Subjects, Including the Elderly and Subjects With Hepatic or Renal Insufficiency

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to compare the safety, tolerance and efficacy of BLI800 (approved and investigational regimens) to an approved control preparation as bowel preparations prior to colonoscopy in adult patients, particularly including the elderly and those with renal and/or hepatic impairment.

Study identification

NCT ID: NCT01501513
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Braintree Laboratories; Industry
Enrollment: 541 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2011 (Type not available)
Primary completion: Mar 4, 2013 (Actual)
Completion: Mar 4, 2013 (Actual)
Last update posted: Jan 17, 2024

2011 – 2013

United States locations

U.S. sites: 17
U.S. states: 12
U.S. cities: 16

Facility	City	State	ZIP	Site status
University of South Alabama	Mobile	Alabama	36693	—
Advanced Clinical Research Institute	Anaheim	California	92801	—
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	—
Borland-Groover Clinic	Jacksonville	Florida	32256	—
Miami Research Associates	South Miami	Florida	33143	—
Indiana University	Indianapolis	Indiana	46202	—
Delta Research Partners	Monroe	Louisiana	71201	—
Commonwealth Clinical Studies	Brockton	Massachusetts	02302	—
Gastrointestinal Associates	Jackson	Mississippi	39202	—
Asheville Gastroenterology Associates	Asheville	North Carolina	28801	—
Carolina Digestive Health Associates	Charlotte	North Carolina	28262	—
Wake Research Associates	Raleigh	North Carolina	27612	—
Consultants for Clinical Research	Cincinnati	Ohio	45219	—
Northwest Gastroenterology	Portland	Oregon	97210	—
ClinSearch	Chattanooga	Tennessee	37421	—
Franklin Gastroenterology	Franklin	Tennessee	37067	—
Charlottesville Medical Research	Charlottesville	Virginia	22911	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01501513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 17, 2024 · Synced Nov 13, 2026